256 related articles for article (PubMed ID: 20847437)
1. Diverse ecdysterones show different effects on amyloid-β42 aggregation but all uniformly inhibit amyloid-β42-induced cytotoxicity.
Yang SG; Zhang X; Sun XS; Ling TJ; Feng Y; Du XY; Zhao M; Yang Y; Xue D; Wang L; Liu RT
J Alzheimers Dis; 2010; 22(1):107-17. PubMed ID: 20847437
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Miyamae Y; Kurisu M; Murakami K; Han J; Isoda H; Irie K; Shigemori H
Bioorg Med Chem; 2012 Oct; 20(19):5844-9. PubMed ID: 22921742
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
4. α-Tocopherol quinone inhibits β-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines.
Yang SG; Wang WY; Ling TJ; Feng Y; Du XT; Zhang X; Sun XX; Zhao M; Xue D; Yang Y; Liu RT
Neurochem Int; 2010 Dec; 57(8):914-22. PubMed ID: 20933033
[TBL] [Abstract][Full Text] [Related]
5. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity.
Feng Y; Yang SG; Du XT; Zhang X; Sun XX; Zhao M; Sun GY; Liu RT
Biochem Biophys Res Commun; 2009 Dec; 390(4):1250-4. PubMed ID: 19878655
[TBL] [Abstract][Full Text] [Related]
6. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.
Chen SY; Chen Y; Li YP; Chen SH; Tan JH; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Sep; 19(18):5596-604. PubMed ID: 21840724
[TBL] [Abstract][Full Text] [Related]
8. Non-toxic conformer of amyloid β may suppress amyloid β-induced toxicity in rat primary neurons: implications for a novel therapeutic strategy for Alzheimer's disease.
Izuo N; Murakami K; Sato M; Iwasaki M; Izumi Y; Shimizu T; Akaike A; Irie K; Kume T
Biochem Biophys Res Commun; 2013 Aug; 438(1):1-5. PubMed ID: 23747423
[TBL] [Abstract][Full Text] [Related]
9. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
10. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
[TBL] [Abstract][Full Text] [Related]
11. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42.
Liu R; Barkhordarian H; Emadi S; Park CB; Sierks MR
Neurobiol Dis; 2005 Oct; 20(1):74-81. PubMed ID: 16137568
[TBL] [Abstract][Full Text] [Related]
12. TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity.
Chonpathompikunlert P; Han J; Toh K; Isoda H; Nagasaki Y
Eur J Pharmacol; 2011 Jan; 650(2-3):544-9. PubMed ID: 20969847
[TBL] [Abstract][Full Text] [Related]
13. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
14. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity?
Saraiva AM; Pereira MC; Brezesinski G
Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050
[TBL] [Abstract][Full Text] [Related]
15. A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.
Xue D; Zhao M; Wang YJ; Wang L; Yang Y; Wang SW; Zhang R; Zhao Y; Liu RT
Neurobiol Dis; 2012 Jun; 46(3):701-9. PubMed ID: 22426388
[TBL] [Abstract][Full Text] [Related]
16. Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease.
Zhou WW; Lu S; Su YJ; Xue D; Yu XL; Wang SW; Zhang H; Xu PX; Xie XX; Liu RT
Free Radic Biol Med; 2014 Sep; 74():50-63. PubMed ID: 24960578
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
[TBL] [Abstract][Full Text] [Related]
18. Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease.
Pinnen F; Sozio P; Cacciatore I; Cornacchia C; Mollica A; Iannitelli A; D'Aurizio E; Cataldi A; Zara S; Nasuti C; Di Stefano A
Arch Pharm (Weinheim); 2011 Mar; 344(3):139-48. PubMed ID: 21384412
[TBL] [Abstract][Full Text] [Related]
19. Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.
Saraiva AM; Cardoso I; Saraiva MJ; Tauer K; Pereira MC; Coelho MA; Möhwald H; Brezesinski G
Macromol Biosci; 2010 Oct; 10(10):1152-63. PubMed ID: 20480510
[TBL] [Abstract][Full Text] [Related]
20. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice.
Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K
J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
